Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GlobeStar Therapeutics Corp

Get SEC filing alerts via email and in your feed for GlobeStar Therapeutics Corp

GSTC

GlobeStar Therapeutics Corp

About GlobeStar Therapeutics Corp

GlobeStar Therapeutics Corporation is a clinical-stage pharmaceutical company focused on developing treatments for multiple sclerosis and neurodegenerative diseases. It owns exclusive licenses for patented formulations and collaborates globally on clinical trials, regulatory filings, and manufacturing. The company aims to commercialize innovative drug candidates, primarily targeting markets in North America, Europe, and Asia, leveraging strategic partnerships and licensing to advance its pipeline.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from GlobeStar Therapeutics Corp

1
1
GlobeStar Therapeutics Corp GlobeStar Therapeutics Reports Improved Financial Performance, Ongoing Challenges in 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments